✦ LIBER ✦

Phase I–II study: clinical and pharmacokinetic data of docetaxel (DTX), carboplatin (CBDCA) and concomitant radiotherapy (RT) in stage IV head and neck cancer

✍ Scribed by M. Airoldi; S. Marchionatti; F. Pedani; M. Danova; V. Recalenda; L. Infante; E. Cagliero; L. Cattel

Book ID: 117658088
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 173 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)80718-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carboplatin (CBDCA) and radiotherapy for

Carboplatin (CBDCA) and radiotherapy for stage IV carcinoma of the head and neck: A phase I–II study

✍ Maria C. Jacobs; Mario Eisenberger; Min Chu Oh; Victoria Sinibaldi; William Gray 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 431 KB

Phase I study of weekly docetaxel (DTX)

Phase I study of weekly docetaxel (DTX) and carboplatin (CBDCA) with concurrent thoracic radiotherapy (TRT) for stage III non-small cell lung cancer (NSCLC)

✍ Murakami, H; Kubota, K; Ohe, Y; Watanabe, H; Sawada, M; Akiyama, Y; Kusaba, H; Y 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Phase I study of concurrent carboplatin

Phase I study of concurrent carboplatin and radiotherapy in previously untreated patients with stage III and IV head and neck cancer

✍ Dr. David Osoba; Dr. Albino D. Flores; Dr. John H. Hay; Dr. Frances Wong; Ms. Ma 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 599 KB

This study evaluated the toxicity resulting from combined therapy using carboplatin and radiotherapy in 22 patients with locally advanced (stage 111 and IV) head and neck cancer. Carboplatin was given after radiotherapy during the first 5 consecutive days of a 16-fraction course of radiotherapy deli

417 14 or 21 consecutive days infusion o

417 14 or 21 consecutive days infusion of carboplatin (CBDCA) and concomitant radiotherapy (RT) in advanced head and neck cancer (HNC): Final report of a feasibility study

✍ L. Marmiroli; L. Nardone; G. Salvi; G. Fiorentino; A.M. Scapati; D. Genovesi; G. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Concomitant Chemoradiotherapy Using Carb

Concomitant Chemoradiotherapy Using Carboplatin, Tegafur-Uracil and Leucovorin for Stage III and IV Head-and-Neck Cancer: Results of GORTEC Phase II Study

✍ Melanie Fesneau; Yoann Pointreau; Sophie Chapet; Laurent Martin; Pascal Pommier; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 228 KB

Phase i/ii study of docetaxel (DOC) and

Phase i/ii study of docetaxel (DOC) and carboplatin (CBDCA) with concurrent radiotherapy in patients with stage III unresectable non-small cell lung cancer (NSCLC), preliminary results

✍ S. Kato; M. Sakura; T. Kazumoto; H. Sakai; S. Yoneda; Y. Noguchi; K. Kobayashi; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 169 KB